drugset / Trial / NCT03280342
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
RandomizedCrossoverSingle-blindTreatment
Summary
Crossover, randomized, double blind: Q12h dosing in both periods; matching placebo for evening dosing during XR treatment; target dose: 100mg
Timeline
- Start
- 2017-10-30
- Primary completion
- 2018-08-20
- Completion
- 2018-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Topiramate | Small molecule | 100 mg | — |